Robert Gallo, born in 1937 in Waterbury, Connecticut, became the most cited scientist globally between 1980 and 1990. His career as an oncologist and virologist focuses on retroviruses and human immunology, notably identifying the cause of acquired immune deficiency syndrome and developing methods to cultivate T cells in laboratory settings for clinical study.
Academic Foundation
Gallo completed his undergraduate studies at Providence College in 1959 before earning a medical degree from Thomas Jefferson University in 1963. Following his medical residency at the University of Chicago, he began a thirty-year tenure at the National Cancer Institute. He served as the head of the Laboratory of Tumor Cell Biology, where he initiated his long-term study of viral oncology and human cellular behavior.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Growth Factors and Viral Discovery
In 1976, Gallo and his team, including Doris Anne Morgan and Frank Ruscetti, achieved a breakthrough by growing T lymphocytes in culture using a substance they identified as T-cell growth factor, later renamed interleukin-2. This development provided the necessary environment to identify the first human retrovirus, the human T-cell leukemia virus. This research earned him the Lasker Award in 1982 for pioneering studies into human RNA tumor viruses.
HIV/AIDS and Scientific Impact
Gallo rose to prominence for his involvement in identifying the agent responsible for AIDS. By 1984, he published research identifying the retrovirus associated with the disease. In 1995, he furthered understanding of immune suppression by publishing work with Paolo Lusso and Fiorenza Cocchi on chemokines as HIV inhibitors. Throughout his career, he has authored over 1,300 scientific papers and maintains memberships in the National Academy of Sciences and the Royal National Academy of Medicine.
Institutional Leadership
In 1996, Gallo co-founded the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore, where he remains active. He serves as the scientific director for the Global Virus Network and holds the title of Homer & Martha Gudelsky Distinguished Professor in Medicine. Additionally, he co-founded the biotechnology firm Profectus BioSciences, Inc.
Fast facts
- Born: 1937, Waterbury
- Education: Providence College, Thomas Jefferson University
- Primary Employer: National Cancer Institute (30 years)
- Scientific Impact Rank (1983–2002): Third in the world
- Key Discovery: Interleukin-2
- Institutional Role: Director, Institute of Human Virology
- Notable Award: Warren Alpert Foundation Prize (1997)
- Total Publications: Over 1,300
Questions readers ask
What is Robert Gallo's primary contribution to immunology?
He developed the methods to grow T lymphocytes in culture and identified human T-cell leukemia virus and the role of chemokines as HIV inhibitors.
Where does Robert Gallo currently work?
He is the director and co-founder of the Institute of Human Virology at the University of Maryland School of Medicine.
Achievements
- Albert Lasker Award for Basic Medical Research — 1982
- Paul Ehrlich and Ludwig Darmstaedter Prize — 1999
- Dickson Prize in Medicine — 1985
- Lasker-DeBakey Clinical Medical Research Award — 1986
- Held posts at National Cancer Institute, University of Maryland School of Medicine and USF Health
- Fields: HIV/AIDS, medicine and infectious diseases
